help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohno, Y.
Right arrow Articles by Nishimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohno, Y.
Right arrow Articles by Nishimura, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1
Hazardous Substances DB
*GLUCOSE

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1072-1077, Copyright © 1993 by Endocrine Society


ARTICLES

In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus

Y Ohno, N Aoki and A Nishimura
Second Department of Medicine, Kinki University School of Medicine, Osaka, Japan.

The in vitro production of interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) by monocytes was examined in patients with insulin-dependent diabetes mellitus (IDDM), in those with noninsulin-dependent diabetes mellitus (NIDDM), and in healthy volunteers. The production of IL-1 and IL-6 by monocytes was significantly lower in IDDM patients than in NIDDM patients and normal subjects whereas the TNF-alpha production by monocytes did not differ between IDDM patients and normal subjects. On the other hand, the TNF- alpha production was significantly higher in NIDDM patients than in IDDM patients and normal subjects. There was a significant correlation between IL-1 and IL-6 concentrations in culture supernatants of monocytes for IDDM patients but not for NIDDM patients and normal subjects. Neither glucose nor insulin showed any stimulatory effect on in vitro production of these monokines. In the serial observation lasting 3-18 months, the monocyte production of IL-1 was found to be consistently reduced in IDDM patients unrelated to the control state of diabetes, suggesting that the reduction of the IL-1 and IL-6 production by monocytes in IDDM patients may be intrinsically affected by immunological defects.


This article has been cited by other articles:


Home page
DiabetesHome page
S. Devaraj, N. Glaser, S. Griffen, J. Wang-Polagruto, E. Miguelino, and I. Jialal
Increased Monocytic Activity and Biomarkers of Inflammation in Patients With Type 1 Diabetes
Diabetes, March 1, 2006; 55(3): 774 - 779.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. K. Jain, K. Kannan, G. Lim, J. Matthews-Greer, R. McVie, and J. A. Bocchini Jr
Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 Monocytes
Diabetes Care, July 1, 2003; 26(7): 2139 - 2143.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Duclos, C. Gouarne, and D. Bonnemaison
Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids
J Appl Physiol, March 1, 2003; 94(3): 869 - 875.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. K. Jain, K. Kannan, G. Lim, R. McVie, and J. A. Bocchini Jr.
Hyperketonemia Increases Tumor Necrosis Factor-{alpha} Secretion in Cultured U937 Monocytes and Type 1 Diabetic Patients and Is Apparently Mediated by Oxidative Stress and cAMP Deficiency
Diabetes, July 1, 2002; 51(7): 2287 - 2293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Soop, H. Duxbury, A. O Agwunobi, J. M. Gibson, S. J. Hopkins, C. Childs, R. G. Cooper, P. Maycock, R. A. Little, and G. L. Carlson
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1276 - E1285.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Katsuki, Y. Sumida, S. Murashima, K. Murata, Y. Takarada, K. Ito, M. Fujii, K. Tsuchihashi, H. Goto, K. Nakatani, et al.
Serum Levels of Tumor Necrosis Factor-{alpha} Are Increased in Obese Patients with Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 859 - 862.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society